Related references
Note: Only part of the references are listed.Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
Ying-Ya Cao et al.
CELL DEATH & DISEASE (2018)
Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells
Gaelle Rondeau et al.
SCIENTIFIC REPORTS (2018)
Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study
Parisa Abedinpour et al.
PROSTATE (2017)
Edible Nanoemulsions as Carriers of Active Ingredients: A Review
Laura Salvia-Trujillo et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 8 (2017)
Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review
Yuling Liu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice
Chi Gu Kang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Nanoemulsions: formation, properties and applications
Ankur Gupta et al.
SOFT MATTER (2016)
Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers
Bilal Bin Hafeez et al.
CANCER PREVENTION RESEARCH (2015)
Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice
Wei Yan et al.
ACTA PHARMACOLOGICA SINICA (2014)
Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo
Sutapa Sinha et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model
Bilal Bin Hafeez et al.
MOLECULAR ONCOLOGY (2013)
The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo
Parisa Abedinpour et al.
PROSTATE (2013)
Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCe, Stat3 and neuroendocrine markers
Bilal Bin Hafeez et al.
CARCINOGENESIS (2012)
Perspectives on medicinal properties of plumbagin and its analogs
Subhash Padhye et al.
MEDICINAL RESEARCH REVIEWS (2012)
Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma
M. R. Sunil Kumar et al.
DRUG DELIVERY (2011)
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications
Yohei Kawabata et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo
Kai-Hong Xu et al.
LEUKEMIA RESEARCH (2010)
Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions
Xiaoyong Wang et al.
FOOD CHEMISTRY (2008)
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development
Jing Jiao et al.
CANCER RESEARCH (2007)
Share Paper
